Emerging investigations focusing on Nexaph amino acid sequences, a distinct category of compounds demonstrating remarkable capability for targeting multiple disease mechanisms. Unlike existing small molecule approaches, these chains offer improved targeting and minimal off-target effects, making them a particularly desirable avenue for future drug